Cytokinetics (CYTK) PT Raised to $48 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cytokinetics (CYTK) PT Raised to $69 at H.C. Wainwright
December 20, 2021 11:44 AM ESTH.C. Wainwright analyst Joseph Pantginis raised the price target on Cytokinetics (NASDAQ: CYTK) to $69.00 (from $62.00) while maintaining a Buy rating.
The analyst commented, "This morning, Cytokinetics and Ji Xing Pharmaceuticals Limited (private) announced an expansion of their existing partnership by entering into an exclusive license and collaboration agreement to develop and commercialize omecamtiv mecarbil for the treatment of HFrEF... More
Cytokinetics (CYTK) Expands Collaboration with JI XING to Include Licensing of Omecamtiv Mecarbil in China
December 20, 2021 7:32 AM ESTCytokinetics, Incorporated (Nasdaq: CYTK) and Ji Xing Pharmaceuticals Limited (JI XING), a biopharmaceutical company based in Shanghai and backed by RTW Investments, LP (RTW), today announced an expansion of their collaboration by entering into an exclusive license and collaboration agreement to develop and commercialize omecamtiv mecarbil for the proposed treatment of heart failure with reduced ejection fraction (HFrEF) in Greater China. In addition to the license and collaboration agreement with JI XING, Cytokinetics has also entered into Common Stock Purchase Agreements that provide for the sale and issuance to entities affiliated with RTW... More
